ROS‐Driven Nanoventilator for MRSA‐Induced Acute Lung Injury Treatment via In Situ Oxygen Supply, Anti‐Inflammation and Immunomodulation
Advanced Science · 2025-05 · 12 (18)
DOI: 10.1002/advs.202406060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.03.2025. Verfasst von Zheng Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cellular Stress Biology, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Scienc…. Hauptthemen laut MEDLINE: Acute Lung Injury, Methicillin-Resistant Staphylococcus aureus, Reactive Oxygen Species, Anti-Inflammatory Agents. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of China, Agency for Science, Technology, and Research.
Abstract (Originalsprache)
Hypoxia, inflammatory response and pathogen (bacterial or viral) infection are the three main factors that lead to death in patients with acute lung injury (ALI). Among them, hypoxia activates the expression of HIF‐1α, further exacerbating the production of ROS and inflammatory response. Currently, anti‐inflammatory and pathogen elimination treatment strategies have effectively alleviated infectious pneumonia, but improving lung hypoxia still faces challenges. Here, a vancomycin‐loaded nanoventilator (SCVN) containing superoxide dismutase (SOD) and catalase (CAT) is developed, which is prepared by encapsulating SOD, CAT and vancomycin into a nanocapsule by in situ polymerization. This nanocapsule can effectively improve the stability and loading rate of enzymes, and enhance their enzyme cascade efficiency, thereby efficiently consuming •O 2 − and H 2 O 2 to generate O 2 in situ and reducing ROS level. More interestingly, in situ O 2 supply can effectively relieve lung hypoxia to reduce HIF‐1α expression and balance the number of M1/M2 macrophages to reduce the levels of TNF‐α, IL‐1β and IL‐6, thereby alleviating the inflammatory response. Meanwhile, vancomycin can target and kill MRSA, fundamentally solving the cause of pneumonia. This nanoventilator with antibacterial, anti‐inflammatory, ROS scavenging and in situ O 2 supply functions will provide a universal clinical treatment strategy for ALI caused by pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cellular Stress Biology, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.
- Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore, 138634, Republic of Singapore.
- Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 1 Pesek Road, Jurong Island, Singapore, 627833, Republic of Singapore.
- Department of Materials Science and Engineering, National University of Singapore, Singapore, 117576, Republic of Singapore.
ORCID-Profile: Zibiao Li
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of China
- Agency for Science, Technology, and Research
- Science and Engineering Research Council
- National Basic Research Program of China
- National Natural Science Foundation of China
Zitieren
APA
Luo, Z., Wang, Q., Fan, X., Koh, X. Q., Loh, X. J., Wu, C., Li, Z., & Wu, Y. L. (2025). ROS‐Driven Nanoventilator for MRSA‐Induced Acute Lung Injury Treatment via In Situ Oxygen Supply, Anti‐Inflammation and Immunomodulation. Advanced Science, 12(18). https://doi.org/10.1002/advs.202406060
Vancouver
Luo Z, Wang Q, Fan X, Koh XQ, Loh XJ, Wu C, et al. ROS‐Driven Nanoventilator for MRSA‐Induced Acute Lung Injury Treatment via In Situ Oxygen Supply, Anti‐Inflammation and Immunomodulation. Advanced Science. 2025;12(18). doi:10.1002/advs.202406060
BibTeX
@article{Luo2025,
author = {Luo, Zheng and Wang, Qi and Fan, Xiaotong and Koh, Xue Qi and Loh, Xian Jun and Wu, Caisheng and Li, Zibiao and Wu, Yun-Long},
title = {ROS‐Driven Nanoventilator for MRSA‐Induced Acute Lung Injury Treatment via In Situ Oxygen Supply, Anti‐Inflammation and Immunomodulation},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {18},
doi = {10.1002/advs.202406060}
}
EUVIMED